I also work in the diagnostic space. GBSN with the current tests, tests in the pipeline (or waiting approval) it should be a $1-4 stock. Yes, there are others like Meridian, Quidel, GenMark, and Qiagen who all trade 12.00 or higher who would love to have GBSN out of the market place OR either have their technology. Something real is happening here this time. I am not new to GBSN, followed it for years, and I am all in.